Morgan Stanley (MS) opened Q2 2026 with total revenue of US$21.3 billion and basic EPS of US$3.50, setting a clear bar for how the business is currently performing. The company has seen quarterly revenue move from US$16.6 billion in Q2 2025 to US$21.3 billion in Q2 2026, while basic EPS over the same quarters shifted from US$2.15 to US$3.50, giving investors a clearer view of how earnings are tracking alongside the top line. With net profit margin over the last 12 months at 25.1%, the latest results highlight a period in which profitability levels are central to how this earnings release is being interpreted.

See our full analysis for Morgan Stanley.

With the headline numbers on the table, the next step is to see how these results relate to widely followed narratives around Morgan Stanley’s growth, risk profile, and profitability story.

Margins and earnings outpace the 5 year trend

• On a trailing basis, Morgan Stanley earned US$19.5b in net income and US$12.51 in basic EPS, with net profit margin at 25.1% compared with 21.6% a year earlier.
• Supporters of the bullish narrative point to this higher margin and 38.2% earnings growth over the last year as evidence that recent profitability can underpin stronger long term earnings power, yet
  • EPS over the last twelve months of US$12.51 versus the five year average growth rate of 5.8% per year shows recent performance running ahead of that longer history.
  • Net profit of US$5.44b in Q2 2026 and US$5.41b in Q1 2026 indicates two consecutive quarters near the current margin level. Bulls may see this as important when thinking about how durable that profitability is.

Bulls argue this kind of earnings profile could justify more optimistic long term expectations, but the recent outperformance versus the five year EPS trend also sets a high bar for what comes next. This is exactly what the more optimistic investors debate in detail in the 🐂 Morgan Stanley Bull Case.

Revenue growth strong, forward expectations more muted

• Trailing twelve month revenue stands at US$77.8b, while forecasts referenced in the analysis point to expected annual revenue growth of 4.4% and earnings growth of 2%, both below the broader US market figures cited at 12.9% for revenue and 18.1% for earnings.
• Critics in the bearish narrative highlight this contrast between strong trailing earnings growth and more modest forecast growth, arguing that recent 38.2% earnings growth may be hard to repeat if secular headwinds play out, and
  • They point to pressures such as fee competition and the shift toward lower cost products as reasons why the 4.4% revenue growth outlook might not match the pace implied by the latest US$21.3b quarterly revenue run rate.
  • They also flag that if margins were to move from 23.9% to 21.8% as assumed in the bearish case, that would be a different path than the 25.1% trailing margin shown in the recent data.

Skeptics suggest this mix of strong trailing growth and more moderate forward expectations is central to their more cautious view, and that trade off between recent results and assumed future growth is unpacked further in the 🐻 Morgan Stanley Bear Case.

Valuation support meets DCF and dividend questions

• At a share price of US$218.37, Morgan Stanley trades on a trailing P/E of 17.6x, below the peer average of 31.6x, the US Capital Markets industry at 40x, and the US market at 19.2x, while the DCF fair value is listed at US$194.23 and the dividend yield at 1.83% with weak free cash flow coverage.
• Consensus style commentary in the analysis notes that this creates mixed signals, with relatively low multiples and improved margins on one side and the DCF fair value sitting below the current price on the other, and
  • The 17.6x P/E combined with a 25.1% net margin and US$19.5b of trailing net income is what some investors focus on when comparing Morgan Stanley with higher multiple peers.
  • At the same time, the DCF fair value of US$194.23 and the observation that the 1.83% dividend is not well covered by free cash flow give income oriented investors specific numbers to weigh against that multiple based support.

Next Steps

To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for Morgan Stanley on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.

If this mix of strong recent results and mixed valuation signals around Morgan Stanley feels balanced rather than conclusive, it may be a good time to review the numbers yourself and decide how they fit your own risk tolerance and income goals. You can begin with the 3 key rewards and 2 important warning signs.

See What Else Is Out There Beyond Morgan Stanley

For Morgan Stanley, the combination of modest 4.4% revenue and 2% earnings forecasts, a DCF fair value below the share price, and weak free cash flow dividend coverage points to softer future support than recent results suggest.

If you are concerned that this mix of slower expected growth, valuation tension, and thin dividend cover could limit your upside, it is worth hunting for companies screened as 50 high quality undervalued stocks to find ideas where pricing and fundamentals may be more closely aligned.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.